CARsgen Therapeutics Holdings Limited (2171.HK)
HKD 15.94
(2.57%)
HKD 15.94
(2.57%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.76 Billion CNY | 17.87% |
| 2022 | -2.14 Billion CNY | -508.25% |
| 2021 | -353.23 Million CNY | 62.53% |
| 2020 | -942.71 Million CNY | -7658.94% |
| 2019 | -12.15 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -1.52 Billion CNY | 5.51% |
| 2024 Q1 | -1.52 Billion CNY | 13.66% |
| 2023 Q4 | -1.76 Billion CNY | 0.69% |
| 2023 FY | -1.76 Billion CNY | 17.87% |
| 2023 Q3 | -1.77 Billion CNY | -12.97% |
| 2023 Q2 | -1.57 Billion CNY | 1.02% |
| 2023 Q1 | -1.58 Billion CNY | 26.04% |
| 2022 Q2 | -256.09 Million CNY | 5.86% |
| 2022 Q1 | -272.05 Million CNY | 22.98% |
| 2022 FY | -2.14 Billion CNY | -508.25% |
| 2022 Q4 | -2.14 Billion CNY | 0.79% |
| 2022 Q3 | -2.16 Billion CNY | -745.67% |
| 2021 FY | -353.23 Million CNY | 62.53% |
| 2021 Q4 | -353.23 Million CNY | 3.82% |
| 2021 Q3 | -367.26 Million CNY | 76.97% |
| 2021 Q2 | -1.59 Billion CNY | 0.71% |
| 2021 Q1 | -1.6 Billion CNY | -70.41% |
| 2020 FY | -942.71 Million CNY | -7658.94% |
| 2020 Q4 | -942.71 Million CNY | 0.62% |
| 2020 Q3 | -948.6 Million CNY | 0.0% |
| 2020 Q1 | 98.43 Million CNY | 0.0% |
| 2019 FY | -12.15 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | -76.36 Million HKD | -2210.534% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.26 Billion HKD | 133.503% |